From billion-dollar megadeals to targeted regional bolt-ons, 2025 was another busy year for mergers and acquisitions across ...

Why This Matters: CPG Manufacturing Runs at a Different Speed Food and beverage manufacturing operates at a fundamentally different speed and level of complexity than most industrial environments.

Laine Mello, director of marketing at Ecolab Bioprocessing, reflects on how the use of digital technologies expanded in the pharma industry in 2025 and how new complex molecules will continue to drive ...

Drug development is notoriously failure-prone. Only one in every ten drug candidates that enter human trials eventually goes onto the market. Turning a promising molecule into a useful medicine ...

This whitepaper explores the role of process analytical technology (PAT) in enhancing the efficiency of upstream ...

Attempting to scry the future of the pharmaceutical industry, professional services juggernaut PwC has laid out lofty ambitions for what it believes drugmakers could achieve by 2035—as well as the ...

Damian Garde is a reporter at large, live and feature journalism, covering the global drug industry and contributing to STAT’s industry-leading events. From the corporate jets of Teterboro Airport to ...

“Industry” burned a lot of things to the ground in Season 3 and a recap of all the chaos is almost a requirement before jumping into the newest episodes. The third season of the HBO series was a ...

Hyderabad-based Natco Pharma Ltd has filed a patent revocation suit against innovator Novo Nordisk for its drug semaglutide, the latest salvo in Indian pharma’s legal offensives against global ...

There’s a lot of talk about narrative and messaging in Season 4 of HBO’s “Industry.” “In America, your story begins when you start telling it,” proclaims one aspiring titan of finance. “Listeners tune ...